SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

IPCA LABORATORIES

BSE: 524494 29 Sep 2025
Healthcare
₹ 1313.4
Ipca Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IPCA LABORATORIES - Share Price & Details

Market Cap
₹34,788
High /Low
1,758 / 1,168
Stock P/E
38.9
Book Value
₹274.0
Dividend Yield
0.29
ROCE
14.7
ROE
₹12.8
Face Value
1.0
PEG Ratio
-26.3
EVEBITDA
₹19.3
Debt
1,363
CMP / FCF
72.4
Debt to equity
₹0.2
NP Ann
785
High price all time
1,758
Piotroski score
₹9.0
Graham Number
435.0
No. Eq. Shares
25.4
Net CF
₹169
Net profit
819
Price to book value
5.01
Interest Coverage
₹18.3
Low price all time
23.5
Industry PE
33.0
Reserves
₹6,923
Free Cash Flow
₹551

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
13 Aug 2025 Prabhudas Lilladher Buy ₹1,376.3 ₹1,525 11.7% moneycontrol View
31 May 2025 Prabhudas Lilladher Buy ₹1,423.95 ₹1,525 7.7% moneycontrol View
14 Feb 2025 Prabhudas Lilladher Buy ₹1,461.8 ₹1,700 16.1% moneycontrol View
27 Dec 2024 Motilal Oswal Buy ₹1,630.55 ₹1,980 19% moneycontrol View
14 Nov 2024 Sharekhan Buy ₹1,536.95 ₹1,765 16.3% moneycontrol View
14 Oct 2024 Motilal Oswal Buy ₹1,681.05 ₹1,950 28.4% moneycontrol View
30 Sep 2024 Sharekhan Buy ₹1,496.7 ₹1,734 14.2% moneycontrol View
15 Aug 2024 Prabhudas Lilladher Sell ₹1,350.7 ₹1,250 -17.5% moneycontrol View
14 Aug 2024 Motilal Oswal Hold ₹1,350.7 ₹1,310 -13.6% moneycontrol View
14 Aug 2024 Sharekhan Buy ₹1,350.7 ₹1,600 5.5% moneycontrol View
03 Jun 2024 Sharekhan Buy ₹1,126.9 ₹1,350 -10.1% moneycontrol View
31 May 2024 Prabhudas Lilladher Buy ₹1,152.1 ₹1,150 -23.4% moneycontrol View
15 Feb 2024 Motilal Oswal Hold ₹1,151.3 ₹1,080 -28.1% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
IPCA LABORATORIES LTD.17719.22620.417469.010.3334,78838.9
Cohance Lifesciences Limited4966.8525.74835.81.373325794.6
Aster DM Healthcare Limited6514.7805.96130.41.573238891.6

Peer Comparison Chart


About IPCA LABORATORIES

Ipca Laboratories Ltd., with Security Code 524494, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Decline in pharma stocks today due to Trump tariff is largely ‘sentimental’ | Business News

(27 Sep 2025)
While Sun Pharma, the heaviest stock on Nifty Pharma, fell as much as 5%, Laurus Labs declined the most—about 6%.
Read more →

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom

(25 Sep 2025)
At a time when Indian markets have ranked among the worst performers in the world over the past 12 months, the pharma sector is witnessing a...
Read more →

Ipca teams with BioSimilar Sciences PR LLC

(25 Sep 2025)
Ipca Laboratories and BioSimilar Sciences PR LLC (BSS) today announced a definitive Technology Transfer and Joint Development Agreement that...
Read more →

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead Indias Pharma Opportunity Boom

(25 Sep 2025)
At a time when Indian markets have ranked among the worst performers in the world over the past 12 months, the pharma sector is witnessing a...
Read more →

Ipca Labs to license cancer, autoimmune disorder drug to US firm BSS

(24 Sep 2025)
Drug firm Ipca Laboratories Ltd on Wednesday (September 24) announced that it has signed a definitive technology transfer and joint...
Read more →

Ipca Labs share price falls 3.35%, among top losers on Nifty Midcap 150

(22 Sep 2025)
Shares of Ipca Labs declined by 3.35%, trading at Rs 1392.70 on Monday. The stock is among the top losers on the Nifty Midcap 150 index.
Read more →